Table of Contents
Chapter 1 Research Methodology & Scope
1.1 Market Segmentation and Scope
1.2 Market Definitions
1.2.1 Molecule Type
1.2.2 Product Type
1.2.3 End - Use
1.3 Research Methodology
1.4 Information Procurement
1.4.1 Information Analysis
1.4.2 Market Formulation & Data Visualization
1.4.3 Data Validation & Publishing
1.5 Research Scope And Assumptions
1.5.1 Commodity Flow Analysis
1.5.2 Top Down Market Estimation
1.5.3 Country Based Segment Share Calculation
1.5.4 Multivariate Analysis
1.5.5 Fill Finish Pharmaceutical Contract Manufacturing Market: Cagr Calculation
1.6 List Of Secondary Sources
1.7 Objectives
1.7.1 Objective - 1:
1.7.2 Objective - 2:
1.7.3 Objective - 3:
1.7.4 Objective - 4:
Chapter 2 Executive Summary
2.1 Market Snapshot
2.2 Segment Snapshot
2.3 Competitive Landscape Snapshot
Chapter 3 Europe Fill - Finish Pharmaceutical Contract Manufacturing Market: Variables, Trends, & Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.2 Ancillary Market Outlook
3.2 Market Dynamics
3.2.1 Market Driver Impact Analysis
3.2.1.1 Increasing Pharmaceutical R&D Expenses
3.2.1.2 Rising Technological Advancements In Fill - Finish Manufacturing Processes
3.2.1.3 Increasing Demand For Fill - Finish Outsourcing
3.2.2 Market Restraint Impact Analysis
3.2.2.1 Stringent Regulatory Issues
3.3 Industry Analysis
3.3.1 Porter’s Five Forces Analysis
3.3.2 Pestel Analysis
3.4 Covid - 19 Impact On Fill - Finish Pharmaceutical Contract Manufacturing Market
3.5 Qualitative Analysis Of The Filling Application Capabilities Of Various Systems
3.5.1 Semi - Automated Mono - Block
3.5.2 High - Speed Filling Lines
3.6 Analysis of the Vision System for Automatic Filling Machines
Chapter 4 Europe Fill - Finish Pharmaceutical Contract Manufacturing Market: Product Type Estimates & Trend Analysis
4.1 Europe Fill - Finish Pharmaceutical Contract Manufacturing Market by Product Type: Key Takeaways
4.2 Product Type Movement Analysis & Market Share, 2022 & 2030
4.3 Europe Fill - Finish Pharmaceutical Contract Manufacturing Market Estimates & Forecast, By Service (USD Million)
4.3.1 Sterile
4.3.1.1 Prefilled Syringes
4.3.1.2 Vials
4.3.1.3 Cartridges
4.3.1.4 Others
4.3.2 Non - Sterile
Chapter 5 Europe Fill - Finish Pharmaceutical Contract Manufacturing Market: Molecule Type Estimates & Trend Analysis
5.1 Europe Fill - Finish Pharmaceutical Contract Manufacturing Market by Molecule Type: Key Takeaways
5.2 Molecule Type Movement Analysis & Market Share, 2022 & 2030
5.3 Fill - Finish Pharmaceutical Contract Manufacturing Market Estimates & Forecast, By Molecule Type (USD Million)
5.3.1 Small Molecules
5.3.2 Large Molecules
Chapter 6 Europe Fill - Finish Pharmaceutical Contract Manufacturing Market: End - Use Estimates & Trend Analysis
6.1 Europe Fill - Finish Pharmaceutical Contract Manufacturing Market By End - Use: Key Takeaways
6.2 End - Use Movement Analysis & Market Share, 2022 & 2030
6.3 Europe Fill - Finish Pharmaceutical Contract Manufacturing Market Estimates & Forecast, By Ens - Use (USD Million)
6.3.1 Biopharmaceutical Companies
6.3.2 Pharmaceutical Companies
Chapter 7 Europe Fill - Finish Pharmaceutical Contract Manufacturing Market: Country Analysis
7.1 Europe
7.1.1 Regulatory Framework
7.1.2 Competitive Scenario
7.1.3 Europe Fill - Finish Pharmaceutical Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.1.8 U.K.
7.1.8.1 Key Country Dynamics
7.1.8.2 U.K. Fill - Finish Pharmaceutical Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
7.1.9 Germany
7.1.9.1 Key Country Dynamics
7.1.9.2 Germany Fill - Finish Pharmaceutical Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.1.10 France
7.1.10.1 Key Country Dynamics
7.1.10.2 France Fill - Finish Pharmaceutical Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.1.11 Italy
7.1.11.1 Key Country Dynamics
7.1.11.2 Italy Fill - Finish Pharmaceutical Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.1.12 Spain
7.1.12.1 Key Country Dynamics
7.1.12.2 Spain Fill - Finish Pharmaceutical Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.1.13 Denmark
7.1.13.1 Key Country Dynamics
7.1.13.2 Denmark Fill - Finish Pharmaceutical Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.1.14 Sweden
7.1.14.1 Key Country Dynamics
7.1.14.2 Sweden Fill - Finish Pharmaceutical Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.1.15 Norway
7.1.15.1 Key Country Dynamics
7.1.15.2 Norway Fill - Finish Pharmaceutical Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.1.16 Switzerland
7.1.16.1 Key Country Dynamics
7.1.16.2 Switzerland Fill - Finish Pharmaceutical Contract Manufacturing Market Estimates And Forecasts, 2018 - 2030 (USD Million)
7.1.17 Belgium
7.1.17.1 Belgium Fill - Finish Pharmaceutical Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
7.1.18 Rest of Europe
7.1.18.1 Rest of Europe Fill - Finish Pharmaceutical Contract Manufacturing Market estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 8 Competitive Landscape
8.1 Company Overview
8.1.1 Thermo Fisher Scientific, Inc.
8.1.2 Sartorius AG
8.1.3 Boehringer Ingelheim
8.1.4 Catalent, Inc.
8.1.5 Societal CDMO (Recro Pharma, Inc)
8.1.6 Baxter BioPharma Solutions
8.1.7 Eurofins Scientific
8.1.8 Symbiosis Pharmaceutical Service
8.1.9 MabPlex International Co. Ltd.
8.1.10 Recipharm AB
8.1.11 Fresenius Kabi Contract Manufacturing
8.1.12 Lonza
8.2 Financial Performance
8.3 Services Benchmarking
8.4 Strategy Mapping
8.4.1.1 Service Launches/Upgrades
8.4.1.2 Mergers/Acquisitions/Joint Ventures
8.4.1.3 Facility/Capacity Expansion
8.4.1.4 Partnerships & Collaborations
8.4.1.5 Regional Expansion
8.4.1.6 Others
8.5 Company Position Heat Map Analysis
Chapter 9 Key Takeaways
List of Tables
表1Molecule type segment definition
Table 2 Product type segment definition
Table 3 End - use segment definition
Table 4 List of secondary sources
Table 5 Europe Fill - Finish Pharmaceutical Contract Manufacturing Market revenue estimates and forecast, by product type, 2018 - 2030 (USD Millions)
Table 6 Europe Fill - Finish Pharmaceutical Contract Manufacturing Market revenue estimates and forecast, by molecule type, 2018 - 2030 (USD Million)
Table 7 Europe Fill - Finish Pharmaceutical Contract Manufacturing Market revenue estimates and forecast, by End - use, 2018 - 2030 (USD Million)
Table 8 Company profiles: Company overview
Table 9 Company profiles: Financial performance
表10 Company profiles: Services benchmarking
表11 Key companies initiating service launches/upgrades.
表12 Key companies initiating mergers/acquisitions/joint ventures.
表13 Key companies initiating facility/capacity expansion.
表14 Key companies initiating partnerships & collaborations
表15 Key companies initiating regional expansion.
表16 Key companies initiating other strategies.
List of Figures
Fig. 1 Fill - Finish Pharmaceutical Contract Manufacturing Market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Data Analysis Models
Fig. 5 Market Formulation And Validation
Fig. 6 Data Validating & Publishing
Fig. 7 Commodity flow analysis
Fig. 8 Market snapshot
Fig. 9 Segment snapshot
Fig. 10 Segment snapshot
Fig. 11 Competitive landscape snapshot
Fig. 12 Global Fill Finish Pharmaceutical Contract Manufacturing Market Value, 2022 (USD Million)
Fig. 13 Healthcare CDMO Market Value, 2022 (USD Million)
Fig. 14 Porter’s five forces analysis
Fig. 15 PEST Analysis
Fig. 16 Fill - finish pharmaceutical contract manufacturing market, by product type: Key takeaways
图17费尔l - finish pharmaceutical contract manufacturing market, by product type: market share, 2022 & 2030
Fig. 18 Sterile market estimates & forecasts, 2018 - 2030 (USD Million)
Fig. 19 Prefilled syringes market estimates & forecasts, 2018 - 2030 (USD Million)
Fig. 20 Vials market estimates & forecasts, 2018 - 2030 (USD Million)
Fig. 21 Cartridges market estimates & forecasts, 2018 - 2030 (USD Million)
Fig. 22 Others market estimates & forecasts, 2018 - 2030 (USD Million)
Fig. 23 Non - sterile market estimates & forecasts, 2018 - 2030 (USD Million)
Fig. 24 Fill - finish pharmaceutical contract manufacturing market, by Molecule type: Key takeaways 61
Fig. 25 Fill - finish pharmaceutical contract manufacturing market, by molecule type: market share, 2022 & 2030
Fig. 26 Small molecules market estimates & forecasts, 2018 - 2030 (USD Million)
Fig. 27 Large Molecules market estimates & forecasts, 2018 - 2030 (USD Million)
Fig. 28 Fill - finish pharmaceutical contract manufacturing market, by end - use: Key takeaways
Fig. 29 Fill - finish pharmaceutical contract manufacturing market, by end - use: market share, 2022 & 2030
Fig. 30 Biopharmaceutical companies market estimates & forecasts, 2018 - 2030 (USD Million)
Fig. 31 Pharmaceutical companies market estimates & forecasts, 2018 - 2030 (USD Million)
Fig. 32 Europe fill - finish pharmaceutical contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 33 Key country dynamics
Fig. 34 Denmark fill - finish pharmaceutical contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 35 Key country dynamics
Fig. 36 Sweden fill - finish pharmaceutical contract manufacturing market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 37 Key country dynamics
图38的关键战略举措市场玩家s